Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29382R107 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
American Century Investment Management, Inc.
13G/A
Amendment 23
|
11.8% |
8/14/2026
Event 6/30/2026
|
|
| American Century Capital Portfolios, Inc. | 5.7% | ||
| American Century Investment Management, Inc. | 11.8% | ||
| American Century Companies, Inc. | 11.8% | ||
| Stowers Institute for Medical Research | 11.8% | ||
|
Gate City Capital Management, LLC
13G/A
Amendment 4
|
7.5% |
8/7/2026
Event 7/31/2026
|
|
| Gate City Capital Management, LLC | 7.5% | ||
| Michael Melby | 7.5% | ||
|
Alexandra Seros
13G
|
10.0% |
5/21/2026
Event 5/19/2026
|
|
| Alexandra Seros, as Trustee of The Survivor's Trust under the Seros Ulloa Family Trust of 1996 | 8.3% | ||
| Alexandra Seros, as Trustee of The Non-Exempt Marital Trust under The Seros Ulloa Family Trust of 1996 | 1.3% | ||
| Alexandra Seros, as Trustee of The Bypass Trust under The Seros Ulloa Family Trust of 1996 | 0.4% | ||
| Alexandra Seros | 10.0% | ||
|
Alexandra Seros
13D/A
Amendment 8
|
11.0% |
5/19/2026
Event 5/15/2026
|
|
| Alexandra Seros, as Trustee of The Survivor's Trust under the Seros Ulloa Family Trust of 1996 | 9.2% | ||
| Alexandra Seros, as Trustee of The Non-Exempt Marital Trust under The Seros Ulloa Family Trust of 1996 | 1.3% | ||
| Alexandra Seros, as Trustee of The Bypass Trust under The Seros Ulloa Family Trust of 1996 | 0.4% | ||
| Thomas Strickler, as Trustee of The Walter F. Ulloa Irrevocable Trust of 1996 | 0.5% | ||
| Alexandra Seros | 11.0% | ||
|
Alexandra Seros
13D/A
Amendment 7
|
12.2% |
5/14/2026
Event 5/13/2026
|
|
| Alexandra Seros, as Trustee of The Survivor's Trust under the Seros Ulloa Family Trust of 1996 | 10.4% | ||
| Alexandra Seros, as Trustee of The Non-Exempt Marital Trust under The Seros Ulloa Family Trust of 1996 | 1.3% | ||
| Alexandra Seros, as Trustee of The Bypass Trust under The Seros Ulloa Family Trust of 1996 | 0.4% | ||
| Thomas Strickler, as Trustee of The Walter F. Ulloa Irrevocable Trust of 1996 | 0.5% | ||
| Alexandra Seros | 12.2% | ||
|
Alexandra Seros
13D/A
Amendment 6
|
13.6% |
5/11/2026
Event 5/7/2026
|
|
| Alexandra Seros, as Trustee of The Survivor's Trust under the Seros Ulloa Family Trust of 1996 | 11.9% | ||
| Alexandra Seros, as Trustee of The Non-Exempt Marital Trust under The Seros Ulloa Family Trust of 1996 | 1.3% | ||
| Alexandra Seros, as Trustee of The Bypass Trust under The Seros Ulloa Family Trust of 1996 | 0.4% | ||
| Thomas Strickler, as Trustee of The Walter F. Ulloa Irrevocable Trust of 1996 | 0.5% | ||
| Alexandra Seros | 13.6% | ||
|
Alexandra Seros
13D/A
Amendment 5
|
14.8% |
5/7/2026
Event 5/7/2026
|
|
| Alexandra Seros, as Trustee of The Survivor's Trust under the Seros Ulloa Family Trust of 1996 | 13.1% | ||
| Alexandra Seros, as Trustee of The Non-Exempt Marital Trust under The Seros Ulloa Family Trust of 1996 | 1.3% | ||
| Alexandra Seros, as Trustee of The Bypass Trust under The Seros Ulloa Family Trust of 1996 | 0.4% | ||
| Thomas Strickler, as Trustee of The Walter F. Ulloa Irrevocable Trust of 1996 | 1.1% | ||
| Alexandra Seros | 14.8% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 22
|
11.1% |
5/1/2026
Event 3/31/2026
|
|
| American Century Capital Portfolios, Inc. | 7.2% | ||
| American Century Investment Management, Inc. | 11.1% | ||
| American Century Companies, Inc. | 11.1% | ||
| Stowers Institute for Medical Research | 11.1% | ||
|
Gate City Capital Management, LLC
13G/A
Amendment 3
|
13.6% |
2/17/2026
Event 12/31/2025
|
|
| Gate City Capital Management, LLC | 13.6% | ||
| Michael Melby | 13.6% | ||
|
Alexandra Seros
13D/A
Amendment 4
|
15.2% |
11/17/2025
Event 11/13/2025
|
|
| Alexandra Seros, as Trustee of The Survivor's Trust under the Seros Ulloa Family Trust of 1996 | 13.4% | ||
| Alexandra Seros, as Trustee of The Non-Exempt Marital Trust under The Seros Ulloa Family Trust of 1996 | 1.3% | ||
| Alexandra Seros, as Trustee of The Bypass Trust under The Seros Ulloa Family Trust of 1996 | 0.4% | ||
| Thomas Strickler, as Trustee of The Walter F. Ulloa Irrevocable Trust of 1996 | 1.1% | ||
| Alexandra Seros | 15.2% | ||
|
American Century Investment Management, Inc.
13G/A
Amendment 21
|
12.1% |
11/14/2025
Event 9/30/2025
|
|
| American Century Capital Portfolios, Inc. | 8.3% | ||
| American Century Investment Management, Inc. | 12.1% | ||
| American Century Companies, Inc. | 12.1% | ||
| Stowers Institute for Medical Research | 12.1% | ||
|
Alexandra Seros
13D/A
Amendment 3
|
16.1% |
8/21/2025
Event 8/19/2025
|
|
| Alexandra Seros, as Trustee of The Survivor's Trust under the Seros Ulloa Family Trust of 1996 | 14.4% | ||
| Alexandra Seros, as Trustee of The Non-Exempt Marital Trust under The Seros Ulloa Family Trust of 1996 | 1.3% | ||
| Alexandra Seros, as Trustee of The Bypass Trust under The Seros Ulloa Family Trust of 1996 | 0.4% | ||
| Thomas Strickler, as Trustee of The Walter F. Ulloa Irrevocable Trust of 1996 | 1.1% | ||
| Alexandra Seros | 16.1% | ||
|
Gate City Capital Management, LLC
13G/A
Amendment 2
|
14.9% |
5/15/2025
Event 3/31/2025
|
|
| Gate City Capital Management, LLC | 14.9% | ||
| Michael Melby | 14.9% | ||
| BlackRock, Inc. 13G/A Amendment 13 | 5.5% |
4/23/2025
Event 3/31/2025
|
|
|
American Century Investment Management, Inc.
13G/A
Amendment 20
|
13.1% |
2/14/2025
Event 12/31/2024
|
|
| American Century Capital Portfolios, Inc. | 9.0% | ||
| American Century Investment Management, Inc. | 13.1% | ||
| American Century Companies, Inc. | 13.1% | ||
| Stowers Institute for Medical Research | 13.1% | ||
|
Gate City Capital Management, LLC
13G/A
Amendment 1
|
12.2% |
11/14/2024
Event 9/30/2024
|
|
| Gate City Capital Management, LLC | 12.2% | ||
| Michael Melby | 12.2% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 2 | 247 | $1.82 k |
| 2026 Q2 | 154 | 57.1 M | $744 M |
| 2026 Q1 | 120 | 47.1 M | $140 M |
| 2025 Q4 | 109 | 47.5 M | $139 M |
| 2025 Q3 | 99 | 47.7 M | $111 M |
| 2025 Q2 | 96 | 48.6 M | $113 M |
| 2025 Q1 | 101 | 48.6 M | $102 M |
| 2024 Q4 | 99 | 48.5 M | $114 M |
| 2024 Q3 | 94 | 47.3 M | $97.9 M |
| 2024 Q2 | 95 | 47.3 M | $96.0 M |
| 2024 Q1 | 108 | 47.5 M | $78.1 M |
| 2023 Q4 | 116 | 52.4 M | $218 M |
| 2023 Q3 | 114 | 49.8 M | $182 M |
| 2023 Q2 | 128 | 50.5 M | $221 M |
| 2023 Q1 | 120 | 49.0 M | $296 M |
| 2022 Q4 | 124 | 49.2 M | $236 M |
| 2022 Q3 | 125 | 47.9 M | $191 M |
| 2022 Q2 | 130 | 49.0 M | $223 M |
| 2022 Q1 | 130 | 48.9 M | $313 M |
| 2021 Q4 | 144 | 49.6 M | $336 M |
| 2021 Q3 | 122 | 48.3 M | $342 M |
| 2021 Q2 | 114 | 46.6 M | $311 M |
| 2021 Q1 | 101 | 45.9 M | $186 M |
| 2020 Q4 | 93 | 51.3 M | $141 M |
| 2020 Q3 | 80 | 46.4 M | $70.6 M |
| 2020 Q2 | 93 | 47.6 M | $68.0 M |
| 2020 Q1 | 92 | 49.6 M | $101 M |
| 2019 Q4 | 102 | 50.2 M | $131 M |
| 2019 Q3 | 100 | 49.8 M | $158 M |
| 2019 Q2 | 121 | 49.9 M | $156 M |
| 2019 Q1 | 115 | 50.1 M | $162 M |
| 2018 Q4 | 118 | 51.2 M | $149 M |
| 2018 Q3 | 135 | 55.2 M | $270 M |
| 2018 Q2 | 131 | 55.1 M | $275 M |
| 2018 Q1 | 136 | 56.6 M | $266 M |
| 2017 Q4 | 154 | 57.2 M | $409 M |
| 2017 Q3 | 130 | 53.6 M | $306 M |
| 2017 Q2 | 126 | 52.5 M | $346 M |
| 2017 Q1 | 132 | 57.9 M | $337 M |
| 2016 Q4 | 125 | 56.0 M | $392 M |
| 2016 Q3 | 122 | 55.5 M | $423 M |
| 2016 Q2 | 137 | 52.0 M | $350 M |
| 2016 Q1 | 139 | 52.1 M | $388 M |
| 2015 Q4 | 149 | 55.4 M | $427 M |
| 2015 Q3 | 133 | 52.5 M | $348 M |
| 2015 Q2 | 126 | 51.6 M | $426 M |
| 2015 Q1 | 111 | 49.8 M | $315 M |
| 2014 Q4 | 108 | 51.3 M | $333 M |
| 2014 Q3 | 108 | 48.2 M | $191 M |
| 2014 Q2 | 126 | 52.6 M | $327 M |
| 2014 Q1 | 128 | 51.5 M | $345 M |